comparemela.com

Latest Breaking News On - Phillip monk - Page 1 : comparemela.com

The Need — And Opportunity — To Develop Broad-Spectrum Antivirals

One factor contributing to the lack of broad-spectrum antivirals is a lag in testing technology for viruses. This article discusses interferons.

United kingdomCenters for diseaseUniversity of southamptonWorld health organizationUnited kingdom health security agencyHarvard universityEuropean centre for disease preventionCanada centre for immunizationPhillip monkDisease controlRespiratory infectious diseasesEuropean centreDisease preventionClinical trials unit

Will increased R&D spending pay off for the Synairgen share price?

Shares in Synairgen flopped after trials for its Covid-19 treatment were put on hold. Investors will be looking at how the company plans to reverse its losses when it delivers its full-year results.

Richard marsdenUniversity of southamptonPhillip monk

Synairgen PLC data analysis provides strong clinical rationale to continue work on Covid treatment

Synairgen PLC data analysis provides strong clinical rationale to continue work on Covid treatment
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoPhillip monkClinical trials symposium

vimarsana © 2020. All Rights Reserved.